Exploring the enigma: history, present, and future of long non-coding RNAs in cancer

Qais Ahmad Naseer1, Abdul Malik1, Fengyuan Zhang1

  • 1Department of Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, 212013, China.

Discover Oncology
|June 7, 2024
PubMed

Insights

Long noncoding RNAs (lncRNAs) regulate gene expression and are implicated in cancer development. Further research is needed to fully understand their mechanisms and therapeutic potential.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Long noncoding RNAs (lncRNAs) are key regulators of gene expression at transcriptional and posttranscriptional levels.
  • lncRNAs exhibit tissue-specific and developmental stage-specific expression, linking them to various processes and diseases, particularly cancer.
  • Despite their potential as biomarkers, the functional mechanisms of lncRNAs are not fully understood, and the extent of functional noncoding transcription in mammals is debated.

Purpose of the Study:

  • To synthesize current knowledge on lncRNA biogenesis, genomic context, and roles in tumorigenesis.
  • To highlight the potential of lncRNAs in cancer-targeted therapy.
  • To discuss historical perspectives and recent breakthroughs in lncRNA research.

Main Methods:

  • Literature review and synthesis of existing research on lncRNAs.
  • Analysis of lncRNA biogenesis and genomic organization.
  • Exploration of lncRNA functions in cancer development and potential therapeutic applications.

Main Results:

  • lncRNAs play multifaceted roles in gene regulation and are involved in numerous biological processes and diseases, including cancer.
  • Specific lncRNAs have been studied in depth, revealing emerging functional themes and mechanistic models.
  • The review consolidates understanding of lncRNA roles in tumorigenesis and their therapeutic potential.

Conclusions:

  • lncRNAs are critical regulators of gene expression with significant implications in cancer.
  • Understanding lncRNA mechanisms is crucial for advancing cancer diagnostics, prognostics, and therapeutics.
  • Further investigation into lncRNA function and biogenesis will enhance our understanding of genome evolution and clinical applications.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
5.7K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K